疫苗的发现和新疫苗技术的翻译
Rino Rappuoli1, Steven Black, Paul Henri Lambert
1Novartis Vaccines, Siena, Italy. rino.rappuoli@novartis.com
Lancet (London, England)
|June 14, 2011
概括
最近疫苗开发的进步使得针对更广泛疾病的疫苗更有效. 新技术有望为各种疾病提供未来的疫苗,改善公共健康和安全.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 在过去的三十年中,疫苗开发取得了重大进展.
- 新疫苗提供了更广泛的保护,更少的注射,并提高了安全性.
研究的目的:
- 审查疫苗开发的最新进展,并探索未来的方向.
- 突出新发现方法及其对疫苗设计的潜在影响.
主要方法:
- 审查新的疫苗发现技术,包括逆向疫苗学,结构生物学和系统生物学.
- 检查新兴的疫苗安全评估技术.
主要成果:
- 开发针对扩大范围传染病的疫苗.
- 引入具有更好的安全性,纯度和注射时间表的疫苗.
- 新疫苗的出现除了传染病之外的新疫苗目标,包括自身免疫疾病和癌症.
结论:
- 未来的疫苗开发将针对不同的人群和疾病,利用创新的发现和安全评估工具.
- 成功实施需要制造商,监管机构和公共卫生计划之间的合作,以确保及时的可用性和公众的信任.
相关概念视频
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Initiation of Translation
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Vaccinations
Overview

